Skip to main content
Top
Published in: Clinical Rheumatology 4/2016

01-04-2016 | Review Article

Rheumatologic manifestations of primary immunodeficiency diseases

Authors: V. R. Dimitriades, R. Sorensen

Published in: Clinical Rheumatology | Issue 4/2016

Login to get access

Abstract

In the last 5 years, several hundred articles have been published concerning the link between primary immunodeficiency disease (PID) and rheumatologic diseases. Although rheumatologic complications were originally thought to be at the opposite ends of the spectrum of immunopathologic manifestations, they are now all being considered secondary manifestations of a causative primary “immune derangement.” For the rheumatologist, it is important to be able to identify patients who may present with typical rheumatologic findings but who have an underlying PID. In a systematic manner, this overview addresses both the systemic and organ-based rheumatologic diseases which have known associations with primary immunodeficiencies, and explores how immunodeficiency may actually cause these clinical manifestations.
Literature
1.
go back to reference Barsalou J, Saint-Cyr C, Drouin E et al (2011) High prevalence of primary immune deficiencies in children with autoimmune disorders. Clin Exp Rheumatol 29:125–130PubMed Barsalou J, Saint-Cyr C, Drouin E et al (2011) High prevalence of primary immune deficiencies in children with autoimmune disorders. Clin Exp Rheumatol 29:125–130PubMed
2.
go back to reference Jesus AA, Liphaus B, Silva C et al (2011) Complement and antibody primary immunodeficiency in juvenile systemic lupus erythematosus patients. Lupus 20:1275–1284CrossRefPubMed Jesus AA, Liphaus B, Silva C et al (2011) Complement and antibody primary immunodeficiency in juvenile systemic lupus erythematosus patients. Lupus 20:1275–1284CrossRefPubMed
3.
go back to reference Spârchez M, Lupan I, Delean D et al (2015) Primary complement and antibody deficiencies in autoimmune rheumatologic diseases with juvenile onset: a prospective study at two centers. Pediatric Rheum 13:51CrossRef Spârchez M, Lupan I, Delean D et al (2015) Primary complement and antibody deficiencies in autoimmune rheumatologic diseases with juvenile onset: a prospective study at two centers. Pediatric Rheum 13:51CrossRef
4.
go back to reference Todoric K, Koontz JB, Mattox D et al (2013) Autoimmunity in immunodeficiency. Curr All Asth Rep 13:361–370CrossRef Todoric K, Koontz JB, Mattox D et al (2013) Autoimmunity in immunodeficiency. Curr All Asth Rep 13:361–370CrossRef
5.
go back to reference Picard C, Al-Herz W, Bousfiha A et al (2015) Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol 35(8):696–726CrossRefPubMedPubMedCentral Picard C, Al-Herz W, Bousfiha A et al (2015) Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol 35(8):696–726CrossRefPubMedPubMedCentral
6.
go back to reference Aringer M, Günther C, Lee-Kirsch MA (2013) Innate immune processes in lupus erythematosus. Clin Immunol 147(3):216–22CrossRefPubMed Aringer M, Günther C, Lee-Kirsch MA (2013) Innate immune processes in lupus erythematosus. Clin Immunol 147(3):216–22CrossRefPubMed
7.
go back to reference Stegert M, Bocka M, Trendelenburg M (2015) Clinical presentation of human C1q deficiency: how much of a lupus? Mol Immunol 67:3–11CrossRefPubMed Stegert M, Bocka M, Trendelenburg M (2015) Clinical presentation of human C1q deficiency: how much of a lupus? Mol Immunol 67:3–11CrossRefPubMed
8.
go back to reference Torgerson T (2012) Immunodeficiency diseases with rheumatic manifestations. Ped Clin N Am 59:493–507CrossRef Torgerson T (2012) Immunodeficiency diseases with rheumatic manifestations. Ped Clin N Am 59:493–507CrossRef
9.
go back to reference Sanford AN, Suriano AR, Herche D et al (2006) Abnormal apoptosis in chronic granulomatous disease and autoantibody production characteristic of lupus. Rheumatology 45:178–181CrossRefPubMed Sanford AN, Suriano AR, Herche D et al (2006) Abnormal apoptosis in chronic granulomatous disease and autoantibody production characteristic of lupus. Rheumatology 45:178–181CrossRefPubMed
10.
go back to reference Kraaij MD, Savage N, van der Kooij S et al (2010) Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc Nat Acad Sci 107:17686–17691CrossRefPubMedPubMedCentral Kraaij MD, Savage N, van der Kooij S et al (2010) Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc Nat Acad Sci 107:17686–17691CrossRefPubMedPubMedCentral
11.
go back to reference De Ravin SS, Naumann N, Cowen E et al (2008) Chronic granulomatous disease as a risk factor for autoimmune disease. J All Clin Immunol 122(6):1097–1103CrossRef De Ravin SS, Naumann N, Cowen E et al (2008) Chronic granulomatous disease as a risk factor for autoimmune disease. J All Clin Immunol 122(6):1097–1103CrossRef
12.
13.
go back to reference Sordet C, Cantagrel A, Schaeverbeke T et al (2005) Bone and joint disease associated with primary immune deficiencies. Joint Bone Spine 72(6):503–14CrossRefPubMed Sordet C, Cantagrel A, Schaeverbeke T et al (2005) Bone and joint disease associated with primary immune deficiencies. Joint Bone Spine 72(6):503–14CrossRefPubMed
14.
go back to reference Pessach I, Notarangelo L (2009) X-linked primary immunodeficiencies as a bridge to better understanding X-chromosome related autoimmunity. J Autoimmunity 33:17–24CrossRef Pessach I, Notarangelo L (2009) X-linked primary immunodeficiencies as a bridge to better understanding X-chromosome related autoimmunity. J Autoimmunity 33:17–24CrossRef
15.
go back to reference Howard V, Greene J, Pahwa S et al (2006) The health status and quality of life of adults with X-linked agammaglobulinemia. Clin Immunol 118:201–208CrossRefPubMed Howard V, Greene J, Pahwa S et al (2006) The health status and quality of life of adults with X-linked agammaglobulinemia. Clin Immunol 118:201–208CrossRefPubMed
16.
go back to reference Hernandez-Trujillo VP, Scalchunes C, Cunningham-Rundles C et al (2014) Autoimmunity and inflammation in X-linked agammaglobulinemia. J Clin Immunol 34(6):627–32CrossRefPubMedPubMedCentral Hernandez-Trujillo VP, Scalchunes C, Cunningham-Rundles C et al (2014) Autoimmunity and inflammation in X-linked agammaglobulinemia. J Clin Immunol 34(6):627–32CrossRefPubMedPubMedCentral
17.
go back to reference McLean-Tooke A, Spickett GP, Gennery AR (2007) Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome. Scan J Immunol 66:1–7CrossRef McLean-Tooke A, Spickett GP, Gennery AR (2007) Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome. Scan J Immunol 66:1–7CrossRef
18.
go back to reference Cron RQ, Sullivan KE (2006) Chronic arthritis without uveitis in velocardiofacial syndrome. J Pediatr 149(2):281CrossRefPubMed Cron RQ, Sullivan KE (2006) Chronic arthritis without uveitis in velocardiofacial syndrome. J Pediatr 149(2):281CrossRefPubMed
19.
go back to reference Pelkonen P, Lahdenne P, Lantto R et al (2002) Chronic arthritis associated with chromosome deletion 22q11.2 syndrome. J Rheumatol 29(12):2648–50PubMed Pelkonen P, Lahdenne P, Lantto R et al (2002) Chronic arthritis associated with chromosome deletion 22q11.2 syndrome. J Rheumatol 29(12):2648–50PubMed
20.
go back to reference Depuis-Girod S, Medioni J, Haddad E et al (2003) Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 111:622–627CrossRef Depuis-Girod S, Medioni J, Haddad E et al (2003) Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 111:622–627CrossRef
21.
go back to reference Akmen I, Ostrov B, Neudorf S (1998) Autoimmune manifestations of the Wiskott-Aldrich syndrome. Semin Arthritis Rheum 27(4):218–25CrossRef Akmen I, Ostrov B, Neudorf S (1998) Autoimmune manifestations of the Wiskott-Aldrich syndrome. Semin Arthritis Rheum 27(4):218–25CrossRef
22.
go back to reference Hill F, Yonkof J, Chaitanya Arudra SK et al (2015) Successful treatment of ANCA-associated vasculitis in the setting of common variable immunodeficiency using rituximab. Am J Ther. DOI: 10.1097/MJT.0000000000000323 Hill F, Yonkof J, Chaitanya Arudra SK et al (2015) Successful treatment of ANCA-associated vasculitis in the setting of common variable immunodeficiency using rituximab. Am J Ther. DOI: 10.​1097/​MJT.​0000000000000323​
23.
go back to reference Catucci M, Castiello MD, Pala F et al (2012) Autoimmunity in Wiskott-Aldrich syndrome: an unsolved enigma. Front Immunol 18(3):209 Catucci M, Castiello MD, Pala F et al (2012) Autoimmunity in Wiskott-Aldrich syndrome: an unsolved enigma. Front Immunol 18(3):209
24.
go back to reference Atkinson TP (2012) Immune deficiency and autoimmunity. Curr Op Rheum 24:515–521CrossRef Atkinson TP (2012) Immune deficiency and autoimmunity. Curr Op Rheum 24:515–521CrossRef
25.
go back to reference Goyal R, Bulua A, Nikolov N et al (2009) Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders. Curr Op Rheum 21:78–84CrossRef Goyal R, Bulua A, Nikolov N et al (2009) Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders. Curr Op Rheum 21:78–84CrossRef
26.
go back to reference Arason GJ, Jorgensen GH, Ludviksson BR (2010) Primary immunodeficiency and autoimmunity: lessons from human diseases. Scan J Immunol 71:317–328CrossRef Arason GJ, Jorgensen GH, Ludviksson BR (2010) Primary immunodeficiency and autoimmunity: lessons from human diseases. Scan J Immunol 71:317–328CrossRef
27.
go back to reference Bussone G, Mouthon L (2009) Autoimmune manifestations in primary immune deficiencies. Autoimm Rev 8:332–336CrossRef Bussone G, Mouthon L (2009) Autoimmune manifestations in primary immune deficiencies. Autoimm Rev 8:332–336CrossRef
28.
go back to reference De Ravin SS, Naumann N, Robinson M (2006) Sarcoidosis in chronic granulomatous disease. Pediatrics 117:591–595CrossRef De Ravin SS, Naumann N, Robinson M (2006) Sarcoidosis in chronic granulomatous disease. Pediatrics 117:591–595CrossRef
29.
go back to reference Moraes-Vansconcelos D, Costa-Carvalho BT, Torgerson T et al (2008) Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED. J Clin Immunol 28(Suppl 1):S11–S19CrossRef Moraes-Vansconcelos D, Costa-Carvalho BT, Torgerson T et al (2008) Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED. J Clin Immunol 28(Suppl 1):S11–S19CrossRef
30.
go back to reference Verbsky J, Routes J (2014) Sarcoidosis and common variable immunodeficiency: similarities and differences. Semin Respir Crit Care Med 35:330–335CrossRefPubMed Verbsky J, Routes J (2014) Sarcoidosis and common variable immunodeficiency: similarities and differences. Semin Respir Crit Care Med 35:330–335CrossRefPubMed
31.
go back to reference Wernantz K, Voll R (2012) Pathogenensis of autoimmunity in common variable immunodeficiency. Front Immunol 18(3):210 Wernantz K, Voll R (2012) Pathogenensis of autoimmunity in common variable immunodeficiency. Front Immunol 18(3):210
32.
33.
go back to reference Legger GE, Wulffraat NM, van Montfrans JM (2016) Chapter 46: immunodeficiencies and the rheumatic diseases. In: Cassidy and Petty’s (ed) Textbook of pediatric rheumatology (7th ed.)., pp 597–608, e5CrossRef Legger GE, Wulffraat NM, van Montfrans JM (2016) Chapter 46: immunodeficiencies and the rheumatic diseases. In: Cassidy and Petty’s (ed) Textbook of pediatric rheumatology (7th ed.)., pp 597–608, e5CrossRef
34.
go back to reference Jesus A, Duarte A, Oliveira J (2008) Autoimmunity in hyper-IgM syndrome. J Clin Immunol 28(Suppl 1):S62–S66CrossRefPubMed Jesus A, Duarte A, Oliveira J (2008) Autoimmunity in hyper-IgM syndrome. J Clin Immunol 28(Suppl 1):S62–S66CrossRefPubMed
36.
go back to reference Barzaghi F, Passerini L, Bacchetta R (2012) Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Front Immunol 18(3):211 Barzaghi F, Passerini L, Bacchetta R (2012) Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Front Immunol 18(3):211
37.
go back to reference Singh K, Chang C, Gershwin ME (2014) IgA deficiency and autoimmunity. Autoimm Rev 13:163–177CrossRef Singh K, Chang C, Gershwin ME (2014) IgA deficiency and autoimmunity. Autoimm Rev 13:163–177CrossRef
38.
go back to reference Weber-Mzell D, Kotanko P, Hauer AC et al (2004) Gender, age and seasonal effects on IgA deficiency: a study of 7293 Caucasians. Eur J Clin Invest 34(3):224–8CrossRefPubMed Weber-Mzell D, Kotanko P, Hauer AC et al (2004) Gender, age and seasonal effects on IgA deficiency: a study of 7293 Caucasians. Eur J Clin Invest 34(3):224–8CrossRefPubMed
39.
go back to reference Jacob C, Pastorino A, Fahl K et al (2008) Autoimmunity in IgA deficiency: revisiting the role of IgA as a silent housekeeper. J Clin Immunol 28(Suppl 1):S56–S61CrossRefPubMed Jacob C, Pastorino A, Fahl K et al (2008) Autoimmunity in IgA deficiency: revisiting the role of IgA as a silent housekeeper. J Clin Immunol 28(Suppl 1):S56–S61CrossRefPubMed
40.
go back to reference Agarwal S, Mayer L (2013) Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol 11(9):1050–63CrossRefPubMedPubMedCentral Agarwal S, Mayer L (2013) Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol 11(9):1050–63CrossRefPubMedPubMedCentral
41.
go back to reference Maggadottir S, Sullivan K (2014) The intersection of immune deficiency and autoimmunity. Curr Op Rheum 26:570–578CrossRef Maggadottir S, Sullivan K (2014) The intersection of immune deficiency and autoimmunity. Curr Op Rheum 26:570–578CrossRef
42.
go back to reference Milner J, Fasth A, Etzioni A (2008) Autoimmunity in severe combined immunodeficiency (SCID): lessons from patients and experimental models. J Clin Immunol 28(Suppl 1):S29–S33CrossRefPubMed Milner J, Fasth A, Etzioni A (2008) Autoimmunity in severe combined immunodeficiency (SCID): lessons from patients and experimental models. J Clin Immunol 28(Suppl 1):S29–S33CrossRefPubMed
44.
go back to reference Martín-Santiago A, Hervás JA, Hervás D et al (2013) Diagnostic value of the skin lesions in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Pediatr Dermatol 30(6):e221–2CrossRefPubMed Martín-Santiago A, Hervás JA, Hervás D et al (2013) Diagnostic value of the skin lesions in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Pediatr Dermatol 30(6):e221–2CrossRefPubMed
45.
go back to reference Sillevis Smitt JH, Kuijpers TW (2013) Cutaneous manifestations of primary immunodeficiency. Curr Opin Pediatr 25(4):492–7CrossRefPubMed Sillevis Smitt JH, Kuijpers TW (2013) Cutaneous manifestations of primary immunodeficiency. Curr Opin Pediatr 25(4):492–7CrossRefPubMed
47.
go back to reference Glerup M, Herlin T, Rittig S et al (2013) Tubulointerstitial nephritis in a patient with probable autoimmune lymphoproliferative syndrome. J Pediatr Hema Oncol 35(5):e187–9CrossRef Glerup M, Herlin T, Rittig S et al (2013) Tubulointerstitial nephritis in a patient with probable autoimmune lymphoproliferative syndrome. J Pediatr Hema Oncol 35(5):e187–9CrossRef
48.
Metadata
Title
Rheumatologic manifestations of primary immunodeficiency diseases
Authors
V. R. Dimitriades
R. Sorensen
Publication date
01-04-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 4/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3229-6

Other articles of this Issue 4/2016

Clinical Rheumatology 4/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.